$TSPT Recent News Stocks to watch Monday: Elan,
Post# of 94143
Posted On: 12/16/2013 12:16:08 PM
$TSPT Recent News
Stocks to watch Monday: Elan, Barnes & Noble 5:46 a.m. Aug. 13, 2012 - MarketWatch
Thursday’s biggest gaining and declining stocks 3:59 p.m. April 26, 2012 - David B. Wilkerson
In focus: Volatility is back! 6:35 p.m. April 11, 2012 - Lawrence G. McMillan
Stocks to watch Wednesday: Regions, Discover 6:00 a.m. March 14, 2012 - MarketWatch
FDA approves Transcept's Intermezzo insomnia drug 3:05 p.m. Nov. 23, 2011 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 1:20 p.m. Oct. 4, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:32 p.m. Sept. 15, 2011 - Kate Gibson
Transcept rockets 100% on FDA update 12:36 p.m. Sept. 15, 2011 - Val Brickates Kennedy
Stock futures up after data; UBS, Netflix off 8:16 a.m. Sept. 15, 2011 - Kate Gibson
Stocks to watch Thursday: RIM, Rockwell Collins 5:47 a.m. Sept. 15, 2011 - MarketWatch
Transcept Pharma climbs in after-hours trade 5:37 p.m. Sept. 14, 2011 - Carla Mozee
Stocks to Watch Thursday: Transcept Pharma 4:15 p.m. Sept. 14, 2011 - David B. Wilkerson
Wednesday’s biggest gaining and declining stocks 3:45 p.m. July 13, 2011 - Dawn Lim
Transcept shares off on FDA sleep drug queries 2:53 p.m. July 13, 2011 - MarketWatch.com
Transcept plunges 40% on FDA setback 10:11 a.m. July 13, 2011 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:11 p.m. June 11, 2009 - MarketWatch
Transcept Provides Update to Key Initiatives to Increase Stockholder Value 8:09 p.m. Dec. 4, 2013 - benzinga.com
Transcept Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:41 p.m. Nov. 9, 2013 - Seeking Alpha
10-Q: TRANSCEPT PHARMACEUTICALS INC 4:54 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Transcept Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 7, 2013 - Seeking Alpha
Transcept Pharma Says Received Request by Retrophin to Buy Up to 15% of Outstanding Shares, Board Decided Not to Accede Request 6:57 a.m. Sept. 30, 2013 - benzinga.com
10-Q: TRANSCEPT PHARMACEUTICALS INC 3:27 p.m. Aug. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Transcept Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript 5:20 p.m. Aug. 7, 2013 - Seeking Alpha
Non-Operating Income Hidden In Operating Earnings 6:47 a.m. June 18, 2013 - Seeking Alpha
SmithOnStocks Opines On Stocks: May 19th Edition 7:32 p.m. May 19, 2013 - Seeking Alpha
SmithOnStocks Opines On Recent Biotech News 4:38 a.m. May 13, 2013 - Seeking Alpha
10-Q: TRANSCEPT PHARMACEUTICALS INC 3:47 p.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Transcept: Throwing In The Towel On Intermezzo 9:46 a.m. May 9, 2013 - Seeking Alpha
Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript 5:10 p.m. May 8, 2013 - Seeking Alpha
Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog 8:43 a.m. May 8, 2013 - Zacks.com
Impax Beats Earnings Estimate - Analyst Blog 7:32 a.m. May 2, 2013 - Zacks.com
AMAG Narrows Loss; Maintains View - Analyst Blog 3:15 p.m. April 24, 2013 - Zacks.com
Merck - BMY in HCV Deal - Analyst Blog 5:10 p.m. April 23, 2013 - Zacks.com
Merck In-Licenses from Xenon - Analyst Blog 4:50 p.m. April 22, 2013 - Zacks.com
Sanofi's Vaccine Gets EU Approval - Analyst Blog 11:10 a.m. April 22, 2013 - Zacks.com
PSTI Plans to Start Phase I Study - Analyst Blog 3:00 p.m. April 19, 2013 - Zacks.com
Retrophin Withdraws Offer for Transcept Pharmaceuticals 9:08 a.m. Today - BusinessWire
Transcept Pharmaceuticals Announces that Glass Lewis & Co. Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders 4:49 p.m. Dec. 13, 2013 - PR Newswire
Transcept Pharmaceuticals Announces that ISS Proxy Advisory Services Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders 4:36 p.m. Dec. 11, 2013 - PR Newswire
Transcept Pharmaceuticals Provides Update to Key Initiatives Being Undertaken to Increase Stockholder Value 8:57 p.m. Dec. 4, 2013 - PR Newswire
Transcept Pharmaceuticals Announces Plans to Reduce Expenses Through a Reduction in Force and a Restructuring of its Board of Directors 7:30 a.m. Nov. 13, 2013 - PR Newswire
Transcept Pharmaceuticals Reports Third Quarter Financial Results 4:05 p.m. Nov. 7, 2013 - PR Newswire
Transcept Pharmaceuticals to Report Third Quarter 2013 Financial Results and Host Conference Call on November 7, 2013 4:15 p.m. Nov. 4, 2013 - PR Newswire
Transcept Sets Special Stockholders Meeting 6:30 a.m. Oct. 7, 2013 - PR Newswire
Transcept Pharmaceuticals Statement on Request by Retrophin, Inc. to Acquire Up To 15 Percent of the Outstanding Common Stock of Transcept 7:40 a.m. Sept. 30, 2013 - PR Newswire
Transcept And Shin Nippon Biomedical Laboratories Announce Global Licensing Agreement For Advanced Acute Migraine Treatment 3:14 p.m. Sept. 25, 2013 - PR Newswire
Transcept Pharmaceuticals Statement on Unsolicited Acquisition Proposal from Retrophin, Inc. 3:05 p.m. Sept. 25, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc. 8:30 p.m. Sept. 20, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on CRME, GTIV, OSUR and TSPT 7:51 a.m. Sept. 20, 2013 - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Transcept Pharmaceuticals' Tax Benefit Preservation Plan and Proposed Acquisition by Retrophin, Inc. 11:55 a.m. Sept. 19, 2013 - BusinessWire
Retrophin Proposes Acquisition of Transcept for $4.00 Per Share 3:00 p.m. Sept. 18, 2013 - BusinessWire
Transcept Pharmaceuticals, Inc. Adopts Tax Benefit Preservation Plan 3:01 p.m. Sept. 13, 2013 - PR Newswire
New Leaf Venture Partners Affirms Its Support of Roumell Asset Management's Letter to Transcept Pharmaceuticals' Board 4:43 p.m. Sept. 9, 2013 - BusinessWire
Transcept Pharmaceuticals Reports Second Quarter Financial Results 3:05 p.m. Aug. 7, 2013 - PR Newswire
Transcept Pharmaceuticals to Report Second Quarter 2013 Financial Results and Host Conference Call on August 7, 2013 4:34 p.m. July 29, 2013 - PR Newswire
Locust Walk Partners Announces Appointment of Chris Ehrlich, Biotechnology Industry and Venture Capital Veteran, as Managing Director 8:27 a.m. May 14, 2013 - Marketwire
Stocks to watch Monday: Elan, Barnes & Noble 5:46 a.m. Aug. 13, 2012 - MarketWatch
Thursday’s biggest gaining and declining stocks 3:59 p.m. April 26, 2012 - David B. Wilkerson
In focus: Volatility is back! 6:35 p.m. April 11, 2012 - Lawrence G. McMillan
Stocks to watch Wednesday: Regions, Discover 6:00 a.m. March 14, 2012 - MarketWatch
FDA approves Transcept's Intermezzo insomnia drug 3:05 p.m. Nov. 23, 2011 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 1:20 p.m. Oct. 4, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:32 p.m. Sept. 15, 2011 - Kate Gibson
Transcept rockets 100% on FDA update 12:36 p.m. Sept. 15, 2011 - Val Brickates Kennedy
Stock futures up after data; UBS, Netflix off 8:16 a.m. Sept. 15, 2011 - Kate Gibson
Stocks to watch Thursday: RIM, Rockwell Collins 5:47 a.m. Sept. 15, 2011 - MarketWatch
Transcept Pharma climbs in after-hours trade 5:37 p.m. Sept. 14, 2011 - Carla Mozee
Stocks to Watch Thursday: Transcept Pharma 4:15 p.m. Sept. 14, 2011 - David B. Wilkerson
Wednesday’s biggest gaining and declining stocks 3:45 p.m. July 13, 2011 - Dawn Lim
Transcept shares off on FDA sleep drug queries 2:53 p.m. July 13, 2011 - MarketWatch.com
Transcept plunges 40% on FDA setback 10:11 a.m. July 13, 2011 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:11 p.m. June 11, 2009 - MarketWatch
Transcept Provides Update to Key Initiatives to Increase Stockholder Value 8:09 p.m. Dec. 4, 2013 - benzinga.com
Transcept Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:41 p.m. Nov. 9, 2013 - Seeking Alpha
10-Q: TRANSCEPT PHARMACEUTICALS INC 4:54 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Transcept Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 7, 2013 - Seeking Alpha
Transcept Pharma Says Received Request by Retrophin to Buy Up to 15% of Outstanding Shares, Board Decided Not to Accede Request 6:57 a.m. Sept. 30, 2013 - benzinga.com
10-Q: TRANSCEPT PHARMACEUTICALS INC 3:27 p.m. Aug. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Transcept Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript 5:20 p.m. Aug. 7, 2013 - Seeking Alpha
Non-Operating Income Hidden In Operating Earnings 6:47 a.m. June 18, 2013 - Seeking Alpha
SmithOnStocks Opines On Stocks: May 19th Edition 7:32 p.m. May 19, 2013 - Seeking Alpha
SmithOnStocks Opines On Recent Biotech News 4:38 a.m. May 13, 2013 - Seeking Alpha
10-Q: TRANSCEPT PHARMACEUTICALS INC 3:47 p.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Transcept: Throwing In The Towel On Intermezzo 9:46 a.m. May 9, 2013 - Seeking Alpha
Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript 5:10 p.m. May 8, 2013 - Seeking Alpha
Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog 8:43 a.m. May 8, 2013 - Zacks.com
Impax Beats Earnings Estimate - Analyst Blog 7:32 a.m. May 2, 2013 - Zacks.com
AMAG Narrows Loss; Maintains View - Analyst Blog 3:15 p.m. April 24, 2013 - Zacks.com
Merck - BMY in HCV Deal - Analyst Blog 5:10 p.m. April 23, 2013 - Zacks.com
Merck In-Licenses from Xenon - Analyst Blog 4:50 p.m. April 22, 2013 - Zacks.com
Sanofi's Vaccine Gets EU Approval - Analyst Blog 11:10 a.m. April 22, 2013 - Zacks.com
PSTI Plans to Start Phase I Study - Analyst Blog 3:00 p.m. April 19, 2013 - Zacks.com
Retrophin Withdraws Offer for Transcept Pharmaceuticals 9:08 a.m. Today - BusinessWire
Transcept Pharmaceuticals Announces that Glass Lewis & Co. Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders 4:49 p.m. Dec. 13, 2013 - PR Newswire
Transcept Pharmaceuticals Announces that ISS Proxy Advisory Services Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders 4:36 p.m. Dec. 11, 2013 - PR Newswire
Transcept Pharmaceuticals Provides Update to Key Initiatives Being Undertaken to Increase Stockholder Value 8:57 p.m. Dec. 4, 2013 - PR Newswire
Transcept Pharmaceuticals Announces Plans to Reduce Expenses Through a Reduction in Force and a Restructuring of its Board of Directors 7:30 a.m. Nov. 13, 2013 - PR Newswire
Transcept Pharmaceuticals Reports Third Quarter Financial Results 4:05 p.m. Nov. 7, 2013 - PR Newswire
Transcept Pharmaceuticals to Report Third Quarter 2013 Financial Results and Host Conference Call on November 7, 2013 4:15 p.m. Nov. 4, 2013 - PR Newswire
Transcept Sets Special Stockholders Meeting 6:30 a.m. Oct. 7, 2013 - PR Newswire
Transcept Pharmaceuticals Statement on Request by Retrophin, Inc. to Acquire Up To 15 Percent of the Outstanding Common Stock of Transcept 7:40 a.m. Sept. 30, 2013 - PR Newswire
Transcept And Shin Nippon Biomedical Laboratories Announce Global Licensing Agreement For Advanced Acute Migraine Treatment 3:14 p.m. Sept. 25, 2013 - PR Newswire
Transcept Pharmaceuticals Statement on Unsolicited Acquisition Proposal from Retrophin, Inc. 3:05 p.m. Sept. 25, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc. 8:30 p.m. Sept. 20, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on CRME, GTIV, OSUR and TSPT 7:51 a.m. Sept. 20, 2013 - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Transcept Pharmaceuticals' Tax Benefit Preservation Plan and Proposed Acquisition by Retrophin, Inc. 11:55 a.m. Sept. 19, 2013 - BusinessWire
Retrophin Proposes Acquisition of Transcept for $4.00 Per Share 3:00 p.m. Sept. 18, 2013 - BusinessWire
Transcept Pharmaceuticals, Inc. Adopts Tax Benefit Preservation Plan 3:01 p.m. Sept. 13, 2013 - PR Newswire
New Leaf Venture Partners Affirms Its Support of Roumell Asset Management's Letter to Transcept Pharmaceuticals' Board 4:43 p.m. Sept. 9, 2013 - BusinessWire
Transcept Pharmaceuticals Reports Second Quarter Financial Results 3:05 p.m. Aug. 7, 2013 - PR Newswire
Transcept Pharmaceuticals to Report Second Quarter 2013 Financial Results and Host Conference Call on August 7, 2013 4:34 p.m. July 29, 2013 - PR Newswire
Locust Walk Partners Announces Appointment of Chris Ehrlich, Biotechnology Industry and Venture Capital Veteran, as Managing Director 8:27 a.m. May 14, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼